Potassium-Competitive Acid Blockers Impacting Competition in the Proton Pump Inhibitors Market
Introducing novel potassium-competitive acid blockers (P-CABs) is reshaping the competitive landscape of acid-related disorder therapeutics within the Proton Pump Inhibitors Market. Newer agents like vonoprazan provide rapid, reversible, and potassium-competitive inhibition of gastric proton pumps. P-CABs achieve full acid suppression on day one of dosing without requiring pre-meal timing...
0 Comments 0 Shares 138 Views 0 Reviews